INTRODUCTION
Although circumferential resection margin (CRM) involvement is a strong predictor of local recurrence in rectal cancer patients, the rate of CRM positivity after rectal surgery is still high despite advancements in surgical techniques [1, 2] . Selective postoperative chemoradiation has been required for patients with CRM involvement [3] .
Recently, an association was reported between neoadjuvant chemoradiotherapy and CRM status [4, 5] . Since CRM has proven to be an effective tool for predicting outcomes following surgery for rectal cancer, previous studies used CRM as a clinical endpoint [2, 5, 6] . Furthermore, it has been suggested that CRM status is more objective than lo-thesurgery.or.kr cal recurrence as an endpoint for rectal cancer studies [7] , and should be included in future staging systems [8] .
The oncologic outcome of lower rectal cancer is inferior to that of upper rectal cancer due to its different anatomical and biologic behaviors [9, 10] and the association with higher CRM involvement [11] . In contrast to the upper rectum, the lower rectum is not covered by the peritoneum, and thus, the extraperitoneal rectum is in direct contact with the pelvic sidewall within the narrow bony pelvis.
Given that a higher incidence of CRM involvement has been found in patients with lower rectal cancer [2, 6, [11] [12] [13] , we hypothesized that achieving a clear CRM for extraperitoneal tumors within the narrow pelvic cavity is more difficult than in intraperitoneal rectal cancer. However, limited data is available with regard to the CRM status of extraperitoneal rectal cancer. Therefore, this retrospective study was designed to identify risk factors of CRM involvement in extraperitoneal rectal cancer and to re-evaluate potential candidates for postoperative adjuvant therapy. 
METHODS

Clinicopathologic features
Pathological evaluation
The surgical specimens were examined grossly and microscopically. In the operating room, a preliminarily macroscopic examination of excised specimens was performed by the surgeons. Tumor perforation was defined as unintended perforation of the tumor irrespective of bowel contents soiling during surgery. The mesorectal surfaces of the resected specimens were painted with Indian ink, and rectal specimens were assessed for mesorectal surface regularity, as follows: Good, intact mesorectum with only minor irregularities in an otherwise [14] . After fixation, resected specimens were sliced transversely through tumors and the mesorectum. Sufficient tissue blocks of primary tumors and suspected metastatic deposits were prepared.
Microscopic CRM was measured using a ruler, and CRMs were considered involved when a microscopic tumor was ＜1 mm from the inked circumferential or radial resection margins. Cancers were staged according to the tumor node metastasis classification (6th edition) [15] .
Statistical analysis
Statistical analysis was conducted using the SPSS ver.
12.0 (SPSS Inc., Chicago, IL, USA 
RESULTS
Clinicopathological characteristics of patients are summarized in Table 1 Logistic regression analysis showed that CRM involvement was significantly associated with male sex, larger tumor size, an advanced T stage, nodal metastasis, tumor perforation, and NSPP ( Table 2 ).
The results of the multivariate analyses of 222 patients with locally advanced tumors (T3-T4 or nodal metastasis)
are shown in Table 3 rate was for tumors 8.0 to 13.0 cm (8 of 85, 9.4%; P = 0.002) ( Table 4 ).
DISCUSSION
CRM status is an accepted important prognostic factor of local recurrence, a measure of quality of surgery, and an indicator of the need for adjuvant treatment [7, 16, 17] . The frequency of CRM involvement remains high, and reported rates were in the range 17 to 28% [7, 14] . Recent studies [2, 5] have reported that the rate of CRM involvement in patients with all types of rectal cancer is somewhat low (range between 5.4% and 12.5%), though this was attributed to the method used for CRM evaluation and the exclusion of patients with distant metastasis.
Different tumor biologies, the technical difficulties of the surgical procedures, and the administration of adjuvant treatment in extraperitoneal rectal cancer [9, 10, 18, 19] suggest the need for studies that focus on the CRM statuses of patients with 'wholly' extraperitoneal rectal cancer.
From a technical and anatomical perspective, it is more difficult to achieve a clear CRM for extraperitoneal tumors.
However, in previous studies of CRM status in rectal cancer [1, 2, 6, 7, 14, 16] , the data for intraperitoneal and extraperitoneal lesions were combined. Therefore, in the present study, we focused our attention on factors associated with CRM involvement in only extraperitoneal rectal cancer, in the hope that the identification of the risk factors of CRM involvement in extraperitoneal rectal cancer would provide data regarding the indications for adjuvant therapy in patients with these risk factors.
The CRM involvement rate of 16.0% in this study is high compared to the results of multicenter studies focusing on evaluating risk factors and prognostic significance of CRM [2, 6, 17] , which reported CRM positivity for all rectal cancer patients of around 10%. Considering the report that patients with lower rectal cancer have higher rates of non-curative resection compared to those with upper rectal cancer [9] , it is assumed to be difficult to achieve negative CRM in 'wholly' extraperitoneal rectal cancer. Therefore, our CRM positivity rate, which is high compared with previous multicenter data [2, 6, 17] , may be explained by technical difficulty associated with curative resection in extraperitoneal rectal cancer.
To our knowledge, the present study is the first to use the anterior peritoneal reflection as a landmark for differentiating extraperitoneal and intraperitoneal lesions based on operative and pathologic findings, rather than on distance from the anal verge. After excluding patients with an intraperitoneal lesion according to our definition, several clinicopathological factors were found to be significantly associated with CRM positivity in extraperitoneal rectal cancer. The predictive factors for CRM involvement were; male sex, larger tumor size (≥4 cm), more than T3, nodal metastasis, tumor perforation, and NSPP. The association between a male sex and greater CRM involvement may be due to difficult surgical access in the narrower male pelvis, which is consistent with a previous study that also reported that male patients were a risk factor for CRM involvement [6] . We also observed that NSPP had an independent effect on CRM involvement, which is supported by previous suggestions that NSPP is a significant risk factor for CRM involvement [1, 2, 6] . This finding implies that postoperative adjuvant therapy is necessary in patients who underwent NSPP due to the higher rate of CRM positivity. The other factors of tumor size, nodal metastasis, and tumor perforation concur with those reported in previous studies that sought to identify predictive factors of CRM involvement for 'all' types of rectal cancers [2, 6, 7] .
In the present study, the rate of CRM involvement was A few studies [1, 9] have demonstrated that tumor height is related to CRM involvement. However, these studies did not assess the rate of CRM involvement with respect to a detailed classification of tumor height. The present study
showed that the rate of CRM positivity for tumors located less than 4 cm from anal verge was remarkably high. This finding suggests that a tumor location around the anal canal necessitates postoperative adjuvant therapy regardless of the type of surgical resection, which is in-line with the recommendation that postoperative chemoradiotherapy is necessary for patients with CRM involvement [3] .
However, the numbers of the patients with tumors around the anal canal are too small to justify this therapeutic recommendation for postoperative adjuvant treatment.
Some limitations of the present study should be noted.
First, oncological outcomes were not analyzed, and therefore, no conclusions could be drawn about the impact of the identified factors on recurrence or survival. Second, although data were prospectively collected, the retrospective nature of this study inherently introduces selection bias.
In conclusion, the rate of CRM involvement after the surgical resection of extraperitoneal rectal cancer was found to be high and to be associated with male sex, larger tumor size, advanced T stage, nodal metastasis, tumor perforation, and NSPP. Given the fact that postoperative chemoradiotherapy is recommended for patients with CRM involvement, further oncologic studies are warranted to ascertain whether extraperitoneal rectal cancer patients with these risk factors should be considered for postoperative adjuvant treatment.
CONFLICTS OF INTEREST
No potential conflict of interest relevant to this article was reported.
